Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Dini

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|May 27, 2026
Gold Nanorod-Radiopharmaceutical Conjugates for Nuclear Medicine Theranostics: A Methodological and Multiscale PerspectiveLudovica Binelli, Andrea Attili, Iole Venditti, et al.
The Journal of Dermatological Treatment|January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort StudyFlaminia Antonelli, Elena Ippoliti, Elia Rosi, et al.
Frontiers in Immunology|January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Frontiers in Public Health|December 28, 2020
Underground Radiobiology: A Perspective at Gran Sasso National LaboratoryGiuseppe Esposito, Pasquale Anello, Marco Ampollini, et al.
Dermatology and Therapy|May 15, 2024
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Biomedicines|October 27, 2022
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective StudyMartina Burlando, Gabriella Fabbrocini, Claudio Marasca, et al.
The Journal of Physical Chemistry. B|March 16, 2026
Peptide-Functionalized Gold Nanorods as a Model to Reach the Cell Nucleus: Synthesis and Structural Characterizations in View of Theragnostic ApplicationsLudovica Binelli, Federica Bertelà, Simone Amatori, et al.
Journal of the American Academy of Dermatology|March 5, 2026
Validation of PARACELSUS score performance for the diagnosis of pyoderma gangrenosum: An international multicenter study with 1403 casesMaurice Moelleken, Alex G Ortega-Loayza, Dorothee Busch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|May 27, 2026
Gold Nanorod-Radiopharmaceutical Conjugates for Nuclear Medicine Theranostics: A Methodological and Multiscale PerspectiveLudovica Binelli, Andrea Attili, Iole Venditti, et al.
The Journal of Dermatological Treatment|January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort StudyFlaminia Antonelli, Elena Ippoliti, Elia Rosi, et al.
Frontiers in Immunology|January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Frontiers in Public Health|December 28, 2020
Underground Radiobiology: A Perspective at Gran Sasso National LaboratoryGiuseppe Esposito, Pasquale Anello, Marco Ampollini, et al.
Dermatology and Therapy|May 15, 2024
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Biomedicines|October 27, 2022
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective StudyMartina Burlando, Gabriella Fabbrocini, Claudio Marasca, et al.
The Journal of Physical Chemistry. B|March 16, 2026
Peptide-Functionalized Gold Nanorods as a Model to Reach the Cell Nucleus: Synthesis and Structural Characterizations in View of Theragnostic ApplicationsLudovica Binelli, Federica Bertelà, Simone Amatori, et al.
Journal of the American Academy of Dermatology|March 5, 2026
Validation of PARACELSUS score performance for the diagnosis of pyoderma gangrenosum: An international multicenter study with 1403 casesMaurice Moelleken, Alex G Ortega-Loayza, Dorothee Busch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Pageof 19